Joint Formulary & PAD

Dalteparin sodium - Pre-operative / bridging therapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Dalteparin sodium
Indication :
Pre-operative / bridging therapy
Group Name :
Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Fragmin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Dalteparin sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pre-operative / bridging therapy.

Committee Recommendations (1)

28 Apr 10 - Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care